Cargando…

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples

AIMS: Activating mutations in the gene encoding epidermal growth factor receptor (EGFR) can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with advanced non-small-cell lung cancer. Testing for mutations in EGFR is therefore an important step in the treatment-deci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellison, Gillian, Zhu, Guanshan, Moulis, Alexandros, Dearden, Simon, Speake, Georgina, McCormack, Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582044/ https://www.ncbi.nlm.nih.gov/pubmed/23172555 http://dx.doi.org/10.1136/jclinpath-2012-201194

Ejemplares similares

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
por: Liu, Xiaoqing, et al.
Publicado: (2013)

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
por: Ellison, Gillian, et al.
Publicado: (2010)

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
por: Douillard, Jean-Yves, et al.
Publicado: (2014)

Evaluation of liquid based cytology in detection of EGFR mutation in NSCLC by large samples
por: Dong, Zhengwei, et al.
Publicado: (2020)

Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
por: Davies, Rhian Siân, et al.
Publicado: (2017)

Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
por: Lee, Seung Eun, et al.
Publicado: (2016)

Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
por: Offerman, Saskia, et al.
Publicado: (2021)

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
por: Liu, Dan, et al.
Publicado: (2014)

Sputum cell‐free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR‐TKIs
por: Wang, Zheng, et al.
Publicado: (2021)

Efficiency of Cytology Samples for PD-L1 Evaluation and Comparison with Tissue Samples
por: Kulaç, İbrahim, et al.
Publicado: (2020)

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting
por: Middleton, Daniel R. S., et al.
Publicado: (2020)

Refractory Pit1 plurihormonal tumours and thyrotroph adenomas
por: NF, Lenders, et al.
Publicado: (2023)

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
por: Douillard, J-Y, et al.
Publicado: (2014)

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients
por: Syahruddin, Elisna, et al.
Publicado: (2018)

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available
por: Ercolani, Cristiana, et al.
Publicado: (2022)

GIANT CELL TUMOUR OF THE TENDON SHEATH – AN UNUSUAL CAUSE FOR LOCKING OF THE KNEE JOINT
por: Napier, Richard, et al.
Publicado: (2008)

Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
por: Arriola, E., et al.
Publicado: (2018)

A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing
por: Ellison, Gillian, et al.
Publicado: (2015)

Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment
por: Kapoor, Simran S., et al.
Publicado: (2021)

Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma
por: Zhao, Huan, et al.
Publicado: (2017)

Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients
por: Wu, Wei, et al.
Publicado: (2020)

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples
por: Brachtel, Elena F., et al.
Publicado: (2016)

Giant-cell tumour of bone: cytological studies.
por: Kasahara, K., et al.
Publicado: (1979)

Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma
por: Ekin, Zübeyde, et al.
Publicado: (2021)

Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer
por: Kunimasa, Kei, et al.
Publicado: (2020)

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
por: Caputo, Alessandro, et al.
Publicado: (2021)

Comparison of conventional Papanicolaou cytology samples with liquid-based cervical cytology samples from women in Pernambuco, Brazil
por: Costa, M.O.L.P., et al.
Publicado: (2015)

International Histological Classification of Tumours: No. 14. Histological and Cytological Typing of Neoplastic Diseases of Haematopoietic and Lymphoid Tissues
por: Dodge, O. G.
Publicado: (1977)

Cytological Smear and Cell Block Versus Tissue Biopsies in the Diagnosis of Malignant Tumours in Non-Gynaecologic Specimens
por: Alwahaibi, Nasar, et al.
Publicado: (2018)

Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
por: Lee, Hyunwoo, et al.
Publicado: (2021)

Cytology and cell‐block immunohistochemistry of circulating tumour cells
por: Mayall, Frederick George, et al.
Publicado: (2019)

The effectiveness of metal on metal hip resurfacing: a systematic review of the available evidence published before 2002
por: Wyness, Laura, et al.
Publicado: (2004)

Multiplex PCR approach to simultaneously identify several mutations in fine needle cytology thyroid samples
por: Vuttariello, Emilia, et al.
Publicado: (2017)

Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer
por: Fujita, Kazutaka, et al.
Publicado: (2021)

The evolution in pituitary tumour classification: a clinical perspective
por: Lenders, Nele F, et al.
Publicado: (2023)

Primary Small Bowel Liposarcoma (Atypical Lipomatous Tumour) with Myogenic Differentiation
por: Patel, J., et al.
Publicado: (2010)

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
por: Board, R E, et al.
Publicado: (2009)

Mutations in normal breast tissue and breast tumours
por: Tomlinson, Ian PM
Publicado: (2001)

Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge
por: Al-Turkmani, M. Rabie, et al.
Publicado: (2020)

Catechin Composition, Phenolic Content, and Antioxidant Properties of Commercially-Available Bagged, Gunpowder, and Matcha Green Teas
por: Meyer, Bailey R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1uc2gr5l66tb37abce20v06p03